SEC 13F Intelligence

Verdad Advisers, LP / ACAD

Verdad Advisers, LP’s Acadia Pharmaceuticals Inc Position

Does Verdad Advisers, LP own Acadia Pharmaceuticals Inc (ACAD)? Yes68.3K shares worth $2M (+1.71% of its 13F portfolio) as of Q1 2026.

Position Value
$2M
Q1 2026
Shares
68.3K
% of Portfolio
+1.71%
Quarters Held
1
currently held

Position History ACAD

Reported value by quarter
Q1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202668.3K$2M+1.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Verdad Advisers, LP’s full portfolio or all institutional holders of ACAD.